Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
InterVest Co.
AddedFeb 13, 2024
UpdatedJul 16, 2026
InterVest Co.

InterVest Co.

Operating

Seoul-based InterVest Co., Ltd. is a venture capital firm specializing in funding startups and early-stage businesses across various sectors in Korea.

Location
Seoul, Seoul, KR
Founded
1999
Firm
Compare
Portfolio
Employees
Website

InterVest Co., Ltd. is a Seoul-based venture capital firm specializing in startups and early-stage businesses across various sectors in Korea. The firm focuses on biotechnology, healthcare, semiconductor, display, energy, telecommunications, software, and digital content industries. InterVest typically invests in Seed to Series C rounds, with a particular emphasis on Series A and B investments.

Notable portfolio companies include Noom, a digital health platform, and Phantom AI, an autonomous driving technology company. InterVest has also invested in promising startups like D&D Pharmatech, Blocko, and Cipherome. The firm's diverse portfolio and sector expertise position it as a key player in Korea's venture capital ecosystem, supporting innovative companies from early stages through to pre-IPO financing.

InterVest Co. - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments14
Current Portfolio Count12
Total Portfolio Exits0

Top Investment Stages

Series A6 (42.9%)
Series B6 (42.9%)
Seed1 (7.1%)
Series C1 (7.1%)

Stage Mix

Series A 43%Series B 43%Seed 7%Series C 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

mogul club logo

mogul club

Cochl logo

Cochl

Phantom AI logo

Phantom AI

Apposter logo

Apposter

PineTree Therapeutics logo

PineTree Therapeutics

Genome Insight logo

Genome Insight

Cipherome logo

Cipherome

Motion2Ai logo

Motion2Ai

Innospace logo

Innospace

D&D Pharmatech logo

D&D Pharmatech

Blocko logo

Blocko

Noom logo

Noom

InterVest Co. - Similar Investment Firms

E&Investment logo

E&Investment

Tinvestment logo

Tinvestment

NHN Investment logo

NHN Investment

ID Ventures logo

ID Ventures

InterVest Capital Partners logo

InterVest Capital Partners

intervest.com

Samsung Venture Investment logo

Samsung Venture Investment

Seoul Investment Partners Co logo

Seoul Investment Partners Co

IMM Investment logo

IMM Investment

LB Investment logo

LB Investment

lbinvestment.com

Shinhan Venture Investment logo

Shinhan Venture Investment

Kolon Investment logo

Kolon Investment

KT investment logo

KT investment

ktinvestment.co.kr

Woori Technology Investment Co logo

Woori Technology Investment Co

Kiwoom investment Co. logo

Kiwoom investment Co.

DaeGyeong Investment logo

DaeGyeong Investment

InterVest Co. - Classification

Also Known As
  • Intervest Co., LTD
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end